| Rank | Clinic Name | Patient Rating | Country | Lead Doctor | experience | Techniques | Best For | Why It’s Ranked | Accreditations |
|---|---|---|---|---|---|---|---|---|---|
| #1 | 4.7 / 5 (55) | Istanbul, Turkey | 24+ years | Consultation and individualized treatment planning | Children with retinoblastoma | Offers specialized ocular oncology services with personalized treatment plans. Clinic has International Health Tourism Authorization Certificate and serves both local and international patients. | International Health Tourism Authorization Certificate, Turkish Medical Association | ||
| #2 | 4.6 / 5 (436) | Istanbul, Turkey | — | — | Chemotherapy, selective intra-arterial chemotherapy, brachytherapy | Pediatric retinoblastoma cases | Offers two specialized treatments for retinoblastoma (SIAC and brachytherapy). Provides chemotherapy with measures to reduce side effects. JCI-accredited hospital with pediatric oncology specialists. | International Organization for Standardization, Joint Commission International | |
| #3 | 4.7 / 5 (496) | Barcelona, Spain | — | 23,000+ treatments | Retinal detachment surgery, membrane peeling, management of proliferative vitreoretinopathy, removal of subretinal silicone oil | Advanced retinal surgery cases | Offers advanced retinal surgery with Dr. Jordi Monés, who has performed 900+ treatments. JCI accredited with a 4.7 patient rating. | Joint Commission International , European Foundation for Quality Management | |
| #4 | 4.6 / 5 (165) | Istanbul, Turkey | — | — | Chemotherapy, enucleation, focused ultrasound ablation (HIFU) | Advanced retinoblastoma cases | Offers specialized chemotherapy protocols and surgical options like enucleation for advanced cases. JCI accredited with pediatric oncology expertise. | International Organization for Standardization, Joint Commission International | |
| #5 | 4.6 / 5 (544) | Istanbul, Turkey | 22+ years | IAC, Radiotherapy, Oncological surgery, Tumor board review, Ocular ultrasound | Candidates for eye-preserving intra-arterial chemotherapy | Intra-arterial chemotherapy preserves the eye by targeting the ophthalmic artery. IASIOS-accredited interventional oncology service (third worldwide) with case reviews by pediatric and ocular oncology professors. | Planetree's Gold Certificate, International Accreditation System for Interventional Oncology Services (IASIOS) | ||
| #6 | 4.5 / 5 (266) | Istanbul, Turkey | 28+ years | Consultation with an ophthalmologist, CT of the paranasal sinuses | — | Pediatric oncology department with MR-LINAC real-time tumor tracking, on-site genetics lab, and multidisciplinary team of 7 specialties. Bone marrow transplant center supports high-risk cases. | Joint Commission International , Turkish Medical Association (Türk Tabıplerı Bırliği) | ||
| #7 | 4.5 / 5 (55) | Istanbul, Turkey | 76+ years | Enucleation of eye, Consultation with an ophthalmologist | Retinoblastoma patients wanting eye and cancer care in the same hospital | — | Joint Commission International | ||
| #8 | 4.8 / 5 (9) | Istanbul, Turkey | 24+ years | Chemotherapy for breast cancer, Consultation with an ophthalmologist | Eye-sparing radiation therapy | Chemotherapy capacity for 40+ patients reduces wait times. Multidisciplinary tumor board plans each case. Dedicated pediatric oncology with 24/7 care and clinical research access. | — | ||
| #9 | 4.5 / 5 (172) | Tel Aviv, Israel | 38+ years34,000+ treatments | Intraarterial chemotherapy | — | Dedicated Children's Eye Health Center and Hemato-Oncology Department. Offers intraarterial chemotherapy and CAR T-cell therapy. Foundation One CDx tests 324 genes. JCI-accredited. Doctors have City of Hope fellowship training. | World's Best Smart Hospitals 2021 by Newsweek, World's Best Hospitals 2021 by Newsweek | ||
| #10 | 5.0 / 5 (2) | Ramat Gan, Israel | 28+ years45,000+ treatments | Enucleation, chemotherapy, radiation therapy, brachytherapy, radiosurgery, laser therapy (photocoagulation, transpupillary thermal therapy), intra-arterial chemotherapy, chemoembolization | Familial retinoblastoma with genetic risk testing | Exclusive brachytherapy provider in Israel for vision preservation. Dedicated Ocular Oncology Center with multidisciplinary board. 96.5% survival rate. | Best Maternity Hospitals 2021 by Newsweek, World's Best Smart Hospitals 2021 by Newsweek |